Expectations trend
FY2028 · fiscal year ending 2028-06-30 · fmp
Freecast Inc (CAST)
NASDAQInformation TechnologyBroadcastingSnapshot 2026-11-04
$1.32+3.13%
Close 2026-11-04 · 1-day change
NASDAQInformation TechnologyBroadcastingSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
0.12 → 0.12 EPS · FY ending Jun 30, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CAST yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain capital allocation strategy | Their capital allocation strategy supports financing needs, which is crucial for recovery. | Intact | capital allocation exceeds 5000000 by 2026-Q4 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 7 of last 7 quarters. The company has consistently executed capital allocation actions including private placements, unregistered equity sales, and a revolving convertible promissory note with a principal amount up to $5 million. These financings have been a persistent focus, with no change in principal amount, indicating steady execution of the capital allocation strategy. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-06-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, loss-making growth bet, not a proven durable compounder. The long-term thesis is in a watch state, with low confidence: management is consistently pursuing financing, but recent operating results remain weak.
CAST is valued at a premium of about 35% versus peers, though confidence in the valuation model is low. The evidence points to some expectations for future opportunity, but does not show that the market assumes a full recovery; the premium sits alongside declining revenue and losses.
Over the near term, recent results and management execution point to continued pressure: revenue and gross profit declined between 2025-Q2 and 2026-Q3, while operating losses widened. Financing has remained a steady priority, but the evidence shows limited progress on reducing losses and an elevated risk of another earnings miss.
The multi-year thesis hinges on revenue and gross profit stabilizing or improving, and operating losses narrowing. Near-term conditions could be helped by lower interest rates or steadier technology-sector leaders, while materially slower economic growth could add pressure.
CAST’s 1-to-3-year view remains uncertain: its valuation premium and financing activity sit against weak operating trends and elevated execution risk. The evidence is limited and confidence is low. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Reduction in operating losses | A supporting condition in Freecast Inc's published investment case. The stated target is <-4421866. | Under Pressure | operating income remains worse than -4421866 next quarter | Operating income: $-4.422M FY2026-Q3; GAAP. Published target: <-4421866. Target period is not explicitly aligned with this observation. May 15, 2026-4,421,866 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 of last 4 quarters. Operating losses have persisted with operating income negative $3.9M in 2025-Q2 and worsening to negative $4.4M in 2026-Q3. Despite management focus on loss reduction, the operating income trend shows limited progress and a slight increase in losses. Delivery assessment Oct 21, 2026 |
Revenue growth improvement | A primary condition in Freecast Inc's published investment case. The stated target is >=384000. | Intact | revenue falls below 384000 next quarter | Revenue: $92,909 FY2026-Q3; GAAP. Published target: >=384000. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. May 15, 202692,909 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 of last 4 quarters. Revenue decreased from $151,545 in 2025-Q2 to $92,909 in 2026-Q3, and gross profit declined from $77,602 to $58,493 over the same period. Despite management emphasis on growth and gross profit improvement, the financials show a declining trajectory in these metrics. Delivery assessment Oct 21, 2026 |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.14 → $0.12 · observed estimates
$0.05B → $0.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-07 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-08 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-09 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-10 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-11 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-12 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-13 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-14 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-15 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-16 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-17 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-18 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-19 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-20 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-21 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-22 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-23 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-24 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-25 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-26 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-27 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-28 | $0.14 | $47,504,500 | 1 / 1 |
| 2026-09-29 | $0.15 | $47,500,000 | 1 / 1 |
| 2026-09-30 | $0.15 | $47,500,000 | 1 / 1 |
| 2026-10-01 | $0.15 | $47,500,000 | 1 / 1 |
| 2026-10-02 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-03 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-04 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-05 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-06 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-07 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-08 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-09 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-10 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-11 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-12 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-13 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-14 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-15 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-16 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-17 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-18 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-19 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-20 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-21 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-22 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-23 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-24 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-25 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-26 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-27 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-28 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-29 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-30 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-10-31 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-11-01 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-11-02 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-11-03 | $0.12 | $47,505,000 | 1 / 1 |
| 2026-11-04 | $0.12 | $47,505,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.